Project Grant HT94252510886
- The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
- This Project Grant award, valued at $574,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this award will fund research to develop innovative methods for targeting and imaging vitamin B5...
- The federal Project Grant award of $328,000 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) for the project "INTRACALVARIAL DRUG DELIVERY STRATEGIES INTO SKULL BONE MARROW TO CREATE AN ANTITUMORAL MYELOID CELL IMMUNE RESPONSE TO GLIOBLASTOMA". The funding period runs from July 1, 2025 to June 30, 2027 and supports advanced biomedical research aimed at...
- This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
- The MCCAIN/BAYH GLIOBLASTOMA CONSORTIUM federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), provides $2,564,517.00 to support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to Duke University's Office of Research Administration on Sep 15, 2025, with a performance period extending through Sep 14, 2029. The...
- This $1,626,438 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports biomedical research conducted by the University of Texas MD Anderson Cancer Center (MD Anderson) to transform healthcare for military service members, veterans, and the general public. The research project, known as the "MCCAIN/BAYH GLIOBLASTOMA CONSORTIUM", will investigate innovative medical solutions for glioblastoma, an aggressive form of...
- This $656,000.00 Project Grant was awarded on May 15, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The funding supports advanced biomedical research focused on "MYELOID CELL AND OTHER INFLAMMATORY COMPONENTS IN THE PROGRESSION OF BARRETT ESOPHAGUS TO INVASIVE ESOPHAGEAL ADENOCARCINOMA". The research aims to transform healthcare for military service...
- This Project Grant award of $1,594,419.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research by The Regents of the University of California, San Francisco (UCSF) on "Radiopathomic Mapping of Tumor Burden for Personalized Management of IDH-Mutant Glioma." The research aims to develop innovative diagnostic and treatment approaches for a specific type of brain cancer through advanced biomedical investigations. This...
- This Federal Project Grant award for $236,777.00 was provided by the Defense Health Agency to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The funding supports RAPID HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA, a research project aimed at developing advanced imaging techniques to better manage patients with glioma, a type of brain cancer. The award term runs...
- The U.S. Defense Health Agency awarded a $1,312,000.00 Project Grant to the Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective August 1, 2025 through July 31, 2029, supports research strategies to upregulate and image Nectin4 to enhance Nectin4-targeted therapies in bladder cancer. As a prominent academic medical center and research institution, UCSF will leverage its expertise in...
This federal Project Grant award of $1,626,500.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research initiative, titled the "MCCAIN/BAYH GLIOBLASTOMA CONSORTIUM," will focus on developing innovative medical solutions to address critical health challenges relevant to military personnel and civilian populations, with a specific emphasis on glioblastoma research. As a prominent academic medical center and research institution, UCSF will leverage its extensive expertise across diverse medical disciplines to execute this complex, multi-year research project grant, which has a period of performance from Sep 15, 2025 through Sep 14, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.6m | 8/11/25 |